The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Iambic Therapeutics完成美国IPO，融资1.5亿美元，以每股16美元发行约938万股，原定区间15至17美元，IPO后市值7.58亿美元，募资用于三款早期抗癌候选药物。 观点网讯：10月15日消息，临床阶段抗癌药物 ...
Iambic Therapeutics (IAM) announced the pricing of its initial public offering of 9.38M shares of common stock at $16.00 per share. The offering is expected to generate gross proceeds of $150M. All ...
The company’s stock is set to start trading on the Nasdaq on Thursday morning under the ticker symbol “IAM.” (VIEW press / Contributor) Iambic Therapeutics’ IPO came in dead on target, bringing in ...
Iambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform, today announced the pricing of its ...
SAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, Inc. (Iambic) (Nasdaq: IAM), a clinical-stage life sciences and technology company advancing novel medicines using its AI-driven platform, today ...
AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800 million if all goes through as planned. The NVIDIA-backed ...
Iambic Therapeutics (IAM), a life sciences company backed by Nvidia (NVDA) and AbbVie (ABBV), among others, on Thursday detailed its plans to go public at a valuation exceeding $800M through a Nasdaq ...
Iambic Therapeutics on Thursday said it plans to sell nearly 9.4 million shares at between $15 and $17 apiece in its initial public offering price. At the $16 midpoint of that price range, the San ...
Iambic already had $207.9 million in cash and cash equivalents at the end of June. (AndreyPopov/iStock/Getty Images Plus) Iambic Therapeutics is aiming for a $135 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results